In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Procyon gains additional patent protection for cancer screening test
Diversa acquires antifungal program from GSK
Diversa and Celera Genomics sequence Streptomyces diversa genome
ImmunoVaccine Technologies Broadens Its Patent Protection to Japan
Diversa announces award of SBIR phase II grants
Diversa and BioProspect Sign Biodiversity Agreement
MorphoSys Strengthens Patent Position on its Core HuCAL Technology in Europe
Evotec OAI Expands Screening Alliance with Pfizer
Expansion of High Content Screening Capabilities at the National Center for Drug Screening in China
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
